Seattle Genetics announces exercise of over-allotment, with offering reaching $178M
This article was originally published in Scrip
Executive Summary
Seattle Genetics said the gross proceeds of its recent stock offering will be $178 million, as opposed to the previously announced $155 million, as underwriters exercised their full option to buy an additional 1.5 million shares of stock.